NovoCure Ltd — Director's Dealing 2019

Apr 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-03-28

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-28	Ordinary Shares	M	23652	$6.72	Acquired	67343	Direct
2019-03-28	Ordinary Shares	M	8869	$7.03	Acquired	76212	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-03-28	Options to Buy Ordinary Shares	$6.72	M	23652	Disposed	2022-07-22	Ordinary Shares (23652)	Direct
2019-03-28	Options to Buy Ordinary Shares	$7.03	M	8869	Disposed	2023-02-19	Ordinary Shares (8869)	Direct

Footnotes

F1: Options exercised were fully vested as of the date hereof.